Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.

Pneumococcal carriage is both immunising and a pre-requisite for mucosal and systemic disease. Murine models of pneumococcal colonisation show that IL-17A-secreting CD4(+) T-cells (Th-17 cells) are essential for clearance of pneumococci from the nasopharynx. Pneumococcal-responding IL-17A-secreting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adam K A Wright, Mathieu Bangert, Jenna F Gritzfeld, Daniela M Ferreira, Kondwani C Jambo, Angela D Wright, Andrea M Collins, Stephen B Gordon
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Acceso en línea:https://doaj.org/article/991ee9a5e40343629520074aa869eb22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:991ee9a5e40343629520074aa869eb22
record_format dspace
spelling oai:doaj.org-article:991ee9a5e40343629520074aa869eb222021-11-18T06:05:51ZExperimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.1553-73661553-737410.1371/journal.ppat.1003274https://doaj.org/article/991ee9a5e40343629520074aa869eb222013-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555269/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Pneumococcal carriage is both immunising and a pre-requisite for mucosal and systemic disease. Murine models of pneumococcal colonisation show that IL-17A-secreting CD4(+) T-cells (Th-17 cells) are essential for clearance of pneumococci from the nasopharynx. Pneumococcal-responding IL-17A-secreting CD4(+) T-cells have not been described in the adult human lung and it is unknown whether they can be elicited by carriage and protect the lung from pneumococcal infection. We investigated the direct effect of experimental human pneumococcal nasal carriage (EHPC) on the frequency and phenotype of cognate CD4(+) T-cells in broncho-alveolar lavage and blood using multi-parameter flow cytometry. We then examined whether they could augment ex vivo alveolar macrophage killing of pneumococci using an in vitro assay. We showed that human pneumococcal carriage leads to a 17.4-fold (p = 0.007) and 8-fold (p = 0.003) increase in the frequency of cognate IL-17A(+) CD4(+) T-cells in BAL and blood, respectively. The phenotype with the largest proportion were TNF(+)/IL-17A(+) co-producing CD4(+) memory T-cells (p<0.01); IFNγ(+) CD4(+) memory T-cells were not significantly increased following carriage. Pneumococci could stimulate large amounts of IL-17A protein from BAL cells in the absence of carriage but in the presence of cognate CD4(+) memory T-cells, IL-17A protein levels were increased by a further 50%. Further to this we then show that alveolar macrophages, which express IL-17A receptors A and C, showed enhanced killing of opsonised pneumococci when stimulated with rhIL-17A (p = 0.013). Killing negatively correlated with RC (r = -0.9, p = 0.017) but not RA expression. We conclude that human pneumococcal carriage can increase the proportion of lung IL-17A-secreting CD4(+) memory T-cells that may enhance innate cellular immunity against pathogenic challenge. These pathways may be utilised to enhance vaccine efficacy to protect the lung against pneumonia.Adam K A WrightMathieu BangertJenna F GritzfeldDaniela M FerreiraKondwani C JamboAngela D WrightAndrea M CollinsStephen B GordonPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 3, p e1003274 (2013)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Adam K A Wright
Mathieu Bangert
Jenna F Gritzfeld
Daniela M Ferreira
Kondwani C Jambo
Angela D Wright
Andrea M Collins
Stephen B Gordon
Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
description Pneumococcal carriage is both immunising and a pre-requisite for mucosal and systemic disease. Murine models of pneumococcal colonisation show that IL-17A-secreting CD4(+) T-cells (Th-17 cells) are essential for clearance of pneumococci from the nasopharynx. Pneumococcal-responding IL-17A-secreting CD4(+) T-cells have not been described in the adult human lung and it is unknown whether they can be elicited by carriage and protect the lung from pneumococcal infection. We investigated the direct effect of experimental human pneumococcal nasal carriage (EHPC) on the frequency and phenotype of cognate CD4(+) T-cells in broncho-alveolar lavage and blood using multi-parameter flow cytometry. We then examined whether they could augment ex vivo alveolar macrophage killing of pneumococci using an in vitro assay. We showed that human pneumococcal carriage leads to a 17.4-fold (p = 0.007) and 8-fold (p = 0.003) increase in the frequency of cognate IL-17A(+) CD4(+) T-cells in BAL and blood, respectively. The phenotype with the largest proportion were TNF(+)/IL-17A(+) co-producing CD4(+) memory T-cells (p<0.01); IFNγ(+) CD4(+) memory T-cells were not significantly increased following carriage. Pneumococci could stimulate large amounts of IL-17A protein from BAL cells in the absence of carriage but in the presence of cognate CD4(+) memory T-cells, IL-17A protein levels were increased by a further 50%. Further to this we then show that alveolar macrophages, which express IL-17A receptors A and C, showed enhanced killing of opsonised pneumococci when stimulated with rhIL-17A (p = 0.013). Killing negatively correlated with RC (r = -0.9, p = 0.017) but not RA expression. We conclude that human pneumococcal carriage can increase the proportion of lung IL-17A-secreting CD4(+) memory T-cells that may enhance innate cellular immunity against pathogenic challenge. These pathways may be utilised to enhance vaccine efficacy to protect the lung against pneumonia.
format article
author Adam K A Wright
Mathieu Bangert
Jenna F Gritzfeld
Daniela M Ferreira
Kondwani C Jambo
Angela D Wright
Andrea M Collins
Stephen B Gordon
author_facet Adam K A Wright
Mathieu Bangert
Jenna F Gritzfeld
Daniela M Ferreira
Kondwani C Jambo
Angela D Wright
Andrea M Collins
Stephen B Gordon
author_sort Adam K A Wright
title Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
title_short Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
title_full Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
title_fullStr Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
title_full_unstemmed Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.
title_sort experimental human pneumococcal carriage augments il-17a-dependent t-cell defence of the lung.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/991ee9a5e40343629520074aa869eb22
work_keys_str_mv AT adamkawright experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT mathieubangert experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT jennafgritzfeld experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT danielamferreira experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT kondwanicjambo experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT angeladwright experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT andreamcollins experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
AT stephenbgordon experimentalhumanpneumococcalcarriageaugmentsil17adependenttcelldefenceofthelung
_version_ 1718424619905449984